[NBIX] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
11-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -132.44%
YoY- -102.10%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 387,900 378,200 310,600 312,000 296,000 288,900 236,600 38.99%
PBT 97,900 -23,300 21,400 -13,800 30,500 57,500 27,200 134.67%
Tax 29,400 -6,400 7,500 -6,500 8,000 15,200 -4,900 -
NP 68,500 -16,900 13,900 -7,300 22,500 42,300 32,100 65.67%
Tax Rate -30.03% - -35.05% - -26.23% -26.43% 18.01% -
Total Cost 319,400 395,100 296,700 319,300 273,500 246,600 204,500 34.57%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 17.66 -4.47 4.48 -2.34 7.60 14.64 13.57 19.18%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS 0.72 -0.18 0.15 -0.08 0.24 0.45 0.34 64.83%
EPS Diluted 0.69 -0.18 0.14 -0.08 0.23 0.43 0.33 63.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.